Tata Motors may not manufacture JLR’s EMA platform-based EVs at its upcoming 90 billion-rupee (approx. 946 million euros) ...

Dehradun: An Indian pharmaceutical firm, whose products Singapore's Health Sciences Authority (HSA) allegedly issued images ...

The agency advises patients to confirm that any cell, gene, or tissue therapy they receive is approved by a regulator or authorized for use in a clinical trial.

Australia and New Zealand will soon see the Geely EX5 hitting their roads. According to the Geely Australia official site, ...

Jaguar Land Rover and Tata Motors end their electric vehicle joint venture in India due to economic challenges and quality ...

JLR's struggle to balance cost and quality in locally sourced components could also affect Tata's upcoming EV projects, ...

Jaguar Land Rover has shelved its plan to manufacture EVs in India at Tata Motors new Tamil Nadu plant. Tap here for more ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

Here are the critical medicines in short supply in the EU, according to the latest available information from the EMA and ...

The global preclinical medical device testing services market is poised for steady expansion, with revenue expected to grow from USD 1,696.0 million in 2025 to USD 2,842.1 million by 2035, at a CAGR ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

BCM (ASX:BCM) says ANSTO testwork has returned in-situ recoveries higher than its recent scoping study on the Ema REE project ...